Take-home naloxone interventions are an effective and simple strategy to reduce opioid overdose morbidity and deaths. The recent PBS-listing of an intranasal naloxone product has the potential to increase uptake of these interventions.
Opioid overdose deaths continue to increase in Australia and are most often associated with the use of prescription opioids and other sedatives. An effective and simple strategy to reduce opioid overdose morbidity and mortality is the provision of take-home naloxone interventions (involving education and supply of naloxone) for patients and carers to use in the event of a suspected overdose in the community. The recent introduction of a PBS-listed intranasal naloxone product has the potential to facilitate uptake of take-home naloxone interventions.